FDA Approves Amivantamab with Chemo for First-Line NSCLC with EGFR Exon 20 Insertion Mutations [EXCLUSIVE VIDEO]
FDA grants approval for amivantamab-vmjw in lung cancer treatment. Find out how this therapy is changing the landscape of NSCLC treatment.